- Home
- GBAB vs OFIX Comparison
GBAB vs OFIX Comparison
Compare GBAB & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GBAB | OFIX |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.0M | 409.0M |
| IPO Year | 2010 | 1998 |
Fundamental Metrics
Financial Performance| Metric | GBAB | OFIX |
|---|---|---|
| Price | $12.42 | $7.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 203.8K | ★ 595.1K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $0.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $12.31 | $6.52 |
| 52 Week High | $15.54 | $16.42 |
Technical Indicators
Market Signals| Indicator | GBAB | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 35.14 |
| Support Level | N/A | N/A |
| Resistance Level | $12.58 | $10.35 |
| Average True Range (ATR) | 0.19 | 0.72 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 9.73 | 17.28 |
Price Performance
Historical ComparisonAbout GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit Income Fund, and others.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.